Erasca

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Erasca and other ETFs, options, and stocks.

About ERAS

Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.

CEO

Jonathan E. Lim

CEOJonathan E. Lim

Employees

103

Employees103

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2018

Founded2018

Employees

103

Employees103

ERAS Key Statistics

Market cap

393.74M

Market cap393.74M

Price-Earnings ratio

-1.86

Price-Earnings ratio-1.86

Dividend yield

—

Dividend yield—

Average volume

1.44M

Average volume1.44M

High today

$1.42

High today$1.42

Low today

$1.33

Low today$1.33

Open price

$1.38

Open price$1.38

Volume

761.73K

Volume761.73K

52 Week high

$3.45

52 Week high$3.45

52 Week low

$1.01

52 Week low$1.01

Analyst ratings

100%

of 9 ratings

Buy

100%

Hold

Sell

Erasca

Why Robinhood?

Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Show more

ERAS Key Statistics

Analyst ratings

100%

Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.